Global Markets for Marine-Derived Pharmaceuticals

Report Highlights

The global market for marine-derived drugs by type was around $4.8 billion in 2011, which is expected to be around $5.3 billion in 2012. This global market is forecasted to reach $8.6 billion by 2016 at a compound annual growth rate (CAGR) of 12.5% for the five year period of 2011 to 2016.

SCOPE OF REPORT

The scope of this study encompasses research organizations, the U.S. government chiefly in the form of the National Cancer Institute (NCI), and companies that develop or help in the development process of pharmaceuticals derived from marine life.  Included are extensive descriptions, perspectives, and predictive information, including forecasts of growth over the next 5 years.  Technological issues, including the latest trends, are discussed.

ANALYST CREDENTIALS

Kim Lawson is a graduate of Mount Holyoke College with a degree in English Literature.  She acquired experience as a healthcare journalist, including working for John Wiley & Sons for years as a print reporter, before serving as a research analyst in a small market research firm that focused on pharmaceuticals and biotechnology in the Research Triangle Park area of North Carolina.  Before joining that firm, Kim published two reports on emerging and established diagnostics and therapeutics for benign and cancerous breast disease.